Taurus Meds charges the same promotional figure for three different peptides against the same anchor — and the research-use language an automated scan finds on its site turns out to be a clause about patient records, not products.
What Taurus Meds charges
NAD+: $79/mo — printed as "NAD+ Injection — Anti-Aging & Cellular Repair — $179 $79 /mo" with the higher figure struck through. ⛔ A promotional figure: the anchor is $179 and the page states no expiry, so this number will decay
Sermorelin: $79/mo — printed as "Sermorelin — Natural Growth Hormone — $179 $79 /mo", the identical promotional figure and identical anchor as this seller's other two peptides. A flat cross-compound price, not a per-compound one
Glutathione: $79/mo — printed as "Glutathione — Master Antioxidant & Energy — $179 $79 /mo". All three peptides on this page carry the same anchor and the same promotional figure, so nothing here distinguishes one compound's cost from another's
Taurus Meds is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
The category flag that was a false positive
An earlier assessment of this seller recorded that the phrase research purposes only appears in the visible text of its privacy policy, noted that this is odd for a prescription telehealth seller, and correctly declined to say which way it cut.
Read in its sentence, it cuts neither way. It is standard privacy-notice language enumerating the circumstances in which protected health information may be disclosed, and the clause names the federal regulation it derives from.
The sentence is about who may see a patient's records. It has no relationship to how the products are made, sold or labelled, and a seller with no research-chemical business at all would carry the identical clause.
This is the clearest false positive of its kind in the batch, and it is recorded here rather than left as a flag, because a flag that is never resolved eventually becomes a finding by attrition.
Three compounds, one price
The peptide page lists a coenzyme, a growth-hormone peptide and an antioxidant. Each has a one-line description, a struck-through anchor, and a figure with a month attached. All three anchors are identical and all three figures are identical.
A flat cross-compound price is a real differentiator for a reader, because it removes the question of which compound is cheaper here. It is also not information about what any compound costs to supply.
None of the three is genuinely priced relative to the others. The number is a marketing position rather than a tariff.
The anchor is more than twice the charged figure and no expiry is stated anywhere, so all three figures will decay together and nothing on the page says when.
The entity disclosure is among the best here
The terms open by naming the operating company, its state of incorporation and its street address including a mailbox number. The same details are repeated in a contact block at the end.
The privacy policy names the same company, and the terms name the clinical partner organisation separately as a managed services organisation.
Against the sellers in this batch whose only published corporate name belongs to a website vendor, a payment processor, a telehealth platform or an arbitration provider, this is a considerably better disclosure than the roster median.
Screened by the operating company, by the clinical partner and by the brand against the regulator's warning-letter index, no letter names this seller.
A clean host and the usual gaps
The nonsense-path control on this host returned a not-found status with an empty body — the cleanest hard not-found in this batch, and the opposite of the hosts here that return a full site for any address.
That matters more than it sounds. On a market where a meaningful minority of hosts answer successfully for paths that do not exist, a host that returns nothing for nothing is one whose successful responses can be trusted.
No dispensing pharmacy is named, no certificate of analysis exists on the pages read, and no state coverage list is published.
The named clinical partner stands behind other brands in this market, so naming it describes the sector rather than distinguishing this seller within it.
Who it's for
Readers who want one figure covering three compounds and no per-compound guesswork.
Buyers who want an operating company, a state of incorporation and a street address published together.
Anyone who wants a dedicated peptide page rather than peptides scattered through a weight-loss catalogue.
Shoppers who want the anchor and the charged figure visible together.
Who should look elsewhere
Anyone relying on the price lasting, since all three figures are promotional against one anchor with no expiry stated.
Readers who want to know what an individual compound costs rather than a flat cross-catalogue rate.
Buyers who want a certificate of analysis or a named dispensing pharmacy.
Shoppers who need a state coverage list.
Strengths
A dedicated peptide route with all three products, their anchors and their figures on one page
Names the operating company, its state of registration and its street address in its own terms
Names the clinical partner organisation separately from the brand
A flat price across three compounds, which removes the guesswork about which one is cheaper here
Trade-offs
Every figure is promotional against the same anchor, with no expiry stated, so all three will decay together
A flat cross-compound price tells a reader nothing about what any individual compound costs to supply
No pharmacy named, no certificate of analysis, no state coverage list
Its clinical partner stands behind other brands, so naming it distinguishes little
How we verified this
Loaded the peptide page, the privacy policy and the terms with a full browser user-agent, printing the effective URL beside the requested one on each.
Ran a nonsense-path control on the host in the same run; it returned a not-found status with an empty body.
Joined the page's text nodes before matching any figure, so a price split across elements could not read as an absence.
Located the research-use phrase in the privacy policy and read the full sentence containing it, including the federal regulation it cites, rather than recording the match.
Recorded that the clause governs disclosure of protected health information and has no bearing on the products, which resolves an earlier flag rather than leaving it open.
Compared all three peptide figures and both anchors and recorded that they are identical.
Read the terms' opening paragraph and contact block for the operating company, its state of incorporation and its address.
Screened the operating company, the clinical partner and the brand against the regulator's warning-letter index, with a nonsense query as a control in the same run.
A provider to compare Taurus Meds against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
No. The research-use phrase on its site is a privacy-notice clause about disclosure of patient records, citing the federal regulation it comes from, and says nothing about the products.
Why do three different peptides cost the same?
The page prices all three at one promotional figure against one anchor. It is a marketing position rather than a per-compound tariff.
Will the price last?
Nothing says. All three figures are promotional against an anchor more than twice their size, and no expiry is stated.
Who operates the brand?
The terms name an incorporated company, its state of incorporation and a street address, and name the clinical partner separately.
Is there a certificate of analysis?
No, and no named dispensing pharmacy or state coverage list either.
Taurus Meds is not a paid partner; this link may earn a commission if that changes. Full disclosure.